The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 3 May 2005
doi: 10.1242/jcs.02352
Research Article
Expression of truncated latent TGF-
protein modulates TGF-
signaling
Roberta Mazzieri,
Vladimir Jurukovski,
Hiroto Obata,
Joanne Sung,
Alec Platt,
Eric Annes,
Nevena Karaman-Jurukovska,
Pierre-Emmanuel Gleizes,
and
Daniel B. Rifkin*
* Author for correspondence (e-mail: rifkid01{at}med.nyu.edu)
Transforming growth factor-
is released from most cells as an inactive complex consisting of transforming growth factor-
, the transforming growth factor-
propeptide and the latent transforming growth factor-
binding protein. We studied the role of latent transforming binding protein in modulating transforming growth factor-
availability by generating transgenic mice that express a truncated form of latent transforming binding protein-1 that binds to transforming growth factor-
but is missing the known N- and C-terminal matrix-binding sequences. As transforming growth factor-
is an inhibitor of keratinocyte proliferation and is involved in the control of hair cycling, we over-expressed the mutated form of latent transforming binding protein under the control of the keratin 14-promoter. Transgenic animals displayed a hair phenotype due to a reduction in keratinocyte proliferation, an abbreviated growth phase and an early initiation of the involution (catagen) phase of the hair cycle. This phenotype appears to result from excess active transforming growth factor-
, as enhanced numbers of pSmad2/3-positive nuclei are observed in transgenic animal skin. These data suggest that the truncated form of latent transforming binding protein-1 competes with wild-type latent transforming binding protein for binding to latent transforming growth factor-
, resulting in latent transforming growth factor-
complexes that fail to be targeted correctly in the extracellular matrix. The mis-localization of the transforming growth factor-
results in inappropriate activation and premature initiation of catagen, thereby illustrating the significance of latent transforming binding protein interaction with transforming growth factor-
in the targeting and activation of latent transforming growth factor-
in addition to previously reported effects on small latent complex secretion.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Tomala, H. Chmelova, T. Mrkvan, B. Rihova, and M. Kovar
In Vivo Expansion of Activated Naive CD8+ T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy
J. Immunol.,
October 15, 2009;
183(8):
4904 - 4912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yoshinaga, H. Obata, V. Jurukovski, R. Mazzieri, Y. Chen, L. Zilberberg, D. Huso, J. Melamed, P. Prijatelj, V. Todorovic, et al.
Perturbation of transforming growth factor (TGF)-ss1 association with latent TGF-{beta} binding protein yields inflammation and tumors
PNAS,
December 2, 2008;
105(48):
18758 - 18763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhao, Y. Wen, M. L. Polan, J. Qiao, and B. H. Chen
Increased expression of latent TGF-{beta} binding protein-1 and fibrillin-1 in human uterine leiomyomata
Mol. Hum. Reprod.,
May 1, 2007;
13(5):
343 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ge and D. S. Greenspan
BMP1 controls TGF{beta}1 activation via cleavage of latent TGF{beta}-binding protein
J. Cell Biol.,
October 9, 2006;
175(1):
111 - 120.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2005